Response Biomedical Corp.

Response Biomedical Corp. Response develops, manufactures and markets rapid diagnostic tests on the RAMP® Platform Response Biomedical Corp. is a Canadian IVD supplier founded in 1991.

Response develops, manufactures and markets rapid on-site diagnostic tests at its world class manufacturing facility in Vancouver, B.C. for use on the RAMP® Platform. RAMP is a fluorescent immunoassay technology (FIA) for acute care testing with quantitative tests for cardiac markers such as Troponin I and NTproBNP, PCT for sepsis, D-dimer, b-hcg and more…

RAMP provides lab quality results direct

ly from whole blood in about 15 minutes and is ideally suited for both point of care (POC) testing and laboratory use. The RAMP® Platform consists of a reader and single-use disposable test cartridges and is available worldwide.

We’re excited to share our latest press release announcing the launch of the RAMP® Xpress.Read the full press release   ...
06/24/2026

We’re excited to share our latest press release announcing the launch of the RAMP® Xpress.
Read the full press release



Response Biomedical Expands Global Diagnostics Portfolio with the Launch of the RAMP Xpress ...

When every minute counts, rapid insight matters.Inflammation doesn't always announce itself — but the results can be cle...
06/23/2026

When every minute counts, rapid insight matters.
Inflammation doesn't always announce itself — but the results can be clear. The new RAMP® X CRP test delivers rapid, reliable C-Reactive Protein results to support timely diagnosis, treatment decisions, and effective patient monitoring.
Now available on RAMP® Xpress

Big milestone! The RAMP® Xpress has officially received Health Canada approval. Introducing the RAMP Xpress — where flex...
06/22/2026

Big milestone! The RAMP® Xpress has officially received Health Canada approval. Introducing the RAMP Xpress — where flexibility meets performance.
Meet the analyzer that adapts to you. The RAMP Xpress delivers lab-quality results in minutes with the flexibility, accuracy, and cost-effectiveness today's clinical environments demand — because your workflow should drive your diagnostics, not the other way around.
Swipe through to see how
01 | Flexible by Design — Batch or single-test capability, portable with an integrated battery, and compatible with multiple sample types.
02 | Accuracy You Can Trust — TRF/FIA technology aligned with established lab methods, backed by reliable 24/7 customer support.
03 | Cost-Effective Performance — Lower upfront investment, no service contracts or hidden fees, and no routine maintenance or calibration required.
High-performance diagnostics that make financial sense.

Most labs verify linearity with a two-point calibration and call it done. But if you're relying on R² to prove accuracy,...
06/19/2026

Most labs verify linearity with a two-point calibration and call it done. But if you're relying on R² to prove accuracy, there's a blind spot in your method you may not know about.
Join us live on 2 July 2026 as Dr. Dheepa Manoharan, Head of Lab Operations and Quality at Thumbay Group, breaks down the science of linearity and what it actually takes to verify reportable range the right way.
You'll walk away knowing how to catch bias that r and R² miss entirely, how to calculate Total Error against CLIA TEa limits, and how to run a multi-level linearity protocol that holds up under audit. https://buff.ly/MaN6Yjt

06/11/2026

As the world gathers to celebrate the beautiful game, we're proud to call Vancouver home—one of the host cities for the FIFA World Cup 2026.
Welcome to Vancouver. Welcome to the beautiful game.

As the world gathers to celebrate the beautiful game, we're proud to call Vancouver home—one of the host cities for the ...
06/11/2026

As the world gathers to celebrate the beautiful game, we're proud to call Vancouver home—one of the host cities for the FIFA World Cup 2026.
Welcome to Vancouver. Welcome to the beautiful game.

Early kidney changes often develop before symptoms are recognized. Our upcoming MAU test is designed to help detect impo...
06/02/2026

Early kidney changes often develop before symptoms are recognized. Our upcoming MAU test is designed to help detect important signals sooner, supporting earlier clinical intervention and patient management. Because earlier insights can help guide better outcomes. Coming soon.

Cardiovascular risk doesn't announce itself. But there are signals — ultra-sensitive ones — that clinicians can now act ...
06/01/2026

Cardiovascular risk doesn't announce itself. But there are signals — ultra-sensitive ones — that clinicians can now act on early, as part of everyday practice. We're making high-sensitivity cardiac care easy. Coming soon.

Not every symptom tells the full story. A key inflammatory marker — measured rapidly as part of routine clinical practic...
05/29/2026

Not every symptom tells the full story. A key inflammatory marker — measured rapidly as part of routine clinical practice — can be the difference between guessing and knowing. We're changing how fast answers arrive. Watch this space.

Address

1781 W 75th Avenue
Vancouver, BC
V6P6P2

Opening Hours

Monday 9am - 4:30pm
Tuesday 9am - 4:30pm
Wednesday 9am - 4:30pm
Thursday 9am - 4:30pm
Friday 9am - 4:30pm

Telephone

+16044566010

Alerts

Be the first to know and let us send you an email when Response Biomedical Corp. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Response Biomedical Corp.:

Share